Broadfin Capital as of March 31, 2016
Portfolio Holdings for Broadfin Capital
Broadfin Capital holds 68 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Horizon Pharma | 13.3 | $138M | 8.3M | 16.57 | |
| iShares Russell 2000 Index (IWM) | 10.7 | $111M | 1.0M | 110.63 | |
| Novadaq Technologies | 5.8 | $61M | 5.5M | 11.09 | |
| Nevro (NVRO) | 5.3 | $55M | 968k | 56.26 | |
| Flamel Technologies | 4.7 | $49M | 4.4M | 11.04 | |
| Retrophin | 3.9 | $40M | 3.0M | 13.66 | |
| Progenics Pharmaceuticals | 3.8 | $39M | 9.0M | 4.36 | |
| Raptor Pharmaceutical | 3.1 | $32M | 7.0M | 4.60 | |
| AngioDynamics (ANGO) | 3.0 | $31M | 2.5M | 12.29 | |
| Heron Therapeutics (HRTX) | 2.7 | $28M | 1.5M | 18.99 | |
| Anacor Pharmaceuticals In | 2.6 | $27M | 500k | 53.45 | |
| La Jolla Pharmaceuticl Com Par | 2.4 | $24M | 1.2M | 20.91 | |
| Aratana Therapeutics | 1.8 | $19M | 3.4M | 5.52 | |
| BioDelivery Sciences International | 1.6 | $17M | 5.2M | 3.23 | |
| Ignyta | 1.5 | $15M | 2.3M | 6.77 | |
| Advaxis | 1.5 | $15M | 1.7M | 9.03 | |
| Cardiovascular Systems | 1.5 | $15M | 1.5M | 10.37 | |
| Aegerion Pharmaceuticals | 1.4 | $15M | 4.0M | 3.70 | |
| Seaspine Holdings | 1.4 | $15M | 1.0M | 14.64 | |
| Aralez Pharmaceuticals | 1.3 | $14M | 3.8M | 3.55 | |
| Medgenics | 1.3 | $13M | 3.0M | 4.40 | |
| Antares Pharma | 1.3 | $13M | 15M | 0.87 | |
| Recro Pharma | 1.2 | $12M | 2.1M | 5.97 | |
| Teligent | 1.1 | $11M | 2.3M | 4.90 | |
| Lion Biotechnologies | 1.0 | $11M | 2.1M | 5.08 | |
| Dynavax Technologies (DVAX) | 1.0 | $11M | 548k | 19.24 | |
| Redhill Biopharma Ltd cmn | 1.0 | $10M | 818k | 12.25 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.9 | $9.6M | 8.2M | 1.17 | |
| Qlt | 0.8 | $8.8M | 4.4M | 1.99 | |
| Endologix | 0.8 | $8.4M | 1.0M | 8.36 | |
| Zogenix | 0.8 | $8.2M | 882k | 9.24 | |
| Paratek Pharmaceuticals | 0.8 | $8.0M | 530k | 15.17 | |
| Derma Sciences | 0.8 | $7.9M | 2.6M | 3.10 | |
| Egalet | 0.8 | $7.8M | 1.1M | 6.86 | |
| Adma Biologics (ADMA) | 0.8 | $7.8M | 964k | 8.09 | |
| Strongbridge Bioph shs usd | 0.7 | $7.6M | 1.7M | 4.56 | |
| XenoPort | 0.7 | $7.2M | 1.6M | 4.51 | |
| Amarin Corporation | 0.7 | $7.2M | 4.7M | 1.53 | |
| Corium Intl | 0.7 | $7.0M | 1.8M | 3.86 | |
| Trevena | 0.7 | $6.7M | 813k | 8.27 | |
| Pernix Therapeutics Holdings | 0.6 | $6.4M | 6.1M | 1.05 | |
| Syneron Medical Ltd ord | 0.6 | $6.4M | 870k | 7.31 | |
| Idera Pharmaceuticals | 0.6 | $6.1M | 3.1M | 1.98 | |
| Alcobra | 0.6 | $5.9M | 1.6M | 3.79 | |
| Biota Pharmaceuticals | 0.5 | $5.2M | 3.5M | 1.50 | |
| Pernix Therapeutics Hldgs In debt | 0.5 | $5.3M | 16M | 0.34 | |
| Dipexium Pharmaceuticals | 0.4 | $4.4M | 466k | 9.51 | |
| Kempharm | 0.4 | $4.3M | 300k | 14.50 | |
| Mediwound Ltd cmn | 0.4 | $4.3M | 531k | 8.07 | |
| Anthera Pharmaceutcls | 0.4 | $4.2M | 1.2M | 3.62 | |
| Mirati Therapeutics | 0.4 | $4.1M | 194k | 21.40 | |
| Tenax Therapeutics | 0.4 | $4.0M | 2.0M | 2.05 | |
| CAS Medical Systems | 0.3 | $3.5M | 2.5M | 1.42 | |
| Nexvet Biopharma Pub Ltd Co ord | 0.3 | $3.3M | 1.0M | 3.30 | |
| Cardica | 0.3 | $3.2M | 888k | 3.56 | |
| Scynexis | 0.3 | $3.0M | 753k | 4.03 | |
| Epirus Biopharmaceuticals In | 0.3 | $2.9M | 1.1M | 2.69 | |
| Contrafect | 0.3 | $2.9M | 845k | 3.40 | |
| Protalix BioTherapeutics | 0.3 | $2.8M | 3.4M | 0.84 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.2 | $2.1M | 167k | 12.70 | |
| Tonix Pharmaceuticls | 0.2 | $2.0M | 826k | 2.41 | |
| Ardelyx (ARDX) | 0.2 | $1.7M | 216k | 7.77 | |
| Rxi Pharmaceuticals | 0.1 | $1.4M | 5.0M | 0.27 | |
| Discovery Laboratories | 0.1 | $1.3M | 778k | 1.67 | |
| Spectranetics Corporation | 0.1 | $1.1M | 73k | 14.51 | |
| Strata Skin Sciences Incorporated | 0.1 | $958k | 1.0M | 0.95 | |
| Ritter Pharmaceuticals | 0.1 | $879k | 778k | 1.13 | |
| Veracyte (VCYT) | 0.1 | $525k | 97k | 5.40 |
